Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity	ALG10B ALG10	3.17e-05	2	113	2	GO:0106073
GeneOntologyMolecularFunction	plus-end directed microfilament motor activity	MYO10 MYO3A	9.49e-05	3	113	2	GO:0060002
GeneOntologyMolecularFunction	glucosyltransferase activity	ALG10B ALG10 UGGT2	2.51e-04	22	113	3	GO:0046527
GeneOntologyMolecularFunction	calmodulin binding	CACNA1A MYO10 UBR4 PHKB MYO3A UNC13C UNC13A	3.37e-04	230	113	7	GO:0005516
GeneOntologyMolecularFunction	sialic acid binding	SIGLEC12 SELP AGRN	3.71e-04	25	113	3	GO:0033691
GeneOntologyBiologicalProcess	muscle atrophy	GATM CFLAR MTOR FBXO32	1.07e-06	15	112	4	GO:0014889
GeneOntologyBiologicalProcess	glycoprotein biosynthetic process	ST6GALNAC1 HS3ST5 C1GALT1 BCL2 RXYLT1 STT3A ALG10B ALG10 UGGT2 DSE	2.52e-05	357	112	10	GO:0009101
GeneOntologyCellularComponent	endocytic vesicle membrane	CYBB ATP6V0A1 GRIA3 AP2M1 EGF PIK3C3 LRP2	1.73e-04	212	115	7	GO:0030666
GeneOntologyCellularComponent	endocytic vesicle	CYBB ATP6V0A1 GRIA3 DYSF AP2M1 EGF PIK3C3 MTOR LRP2	2.75e-04	384	115	9	GO:0030139
GeneOntologyCellularComponent	cytoplasmic vesicle membrane	CYBB SELP LILRA3 ATP6V0A1 UBR4 ENTHD1 GRIA3 DYSF AP2M1 EGF PIK3C3 ANO6 AP5M1 LRP2 UNC13C UNC13A DSE ECE2	2.76e-04	1307	115	18	GO:0030659
GeneOntologyCellularComponent	vesicle membrane	CYBB SELP LILRA3 ATP6V0A1 UBR4 ENTHD1 GRIA3 DYSF AP2M1 EGF PIK3C3 ANO6 AP5M1 LRP2 UNC13C UNC13A DSE ECE2	3.25e-04	1325	115	18	GO:0012506
Domain	Alg10	ALG10B ALG10	3.63e-05	2	113	2	IPR016900
Domain	DIE2_ALG10	ALG10B ALG10	3.63e-05	2	113	2	PF04922
Domain	LY	EGF LRP2 ROS1	9.31e-05	15	113	3	SM00135
Domain	LDLR_classB_rpt	EGF LRP2 ROS1	9.31e-05	15	113	3	IPR000033
Domain	Unc-13	UNC13C UNC13A	1.08e-04	3	113	2	IPR027080
Domain	Cyt_b245_heavy_chain	CYBB NOX1	2.16e-04	4	113	2	IPR000778
Domain	Munc13_dom-2	UNC13C UNC13A	3.59e-04	5	113	2	IPR014772
Domain	MHD2	UNC13C UNC13A	3.59e-04	5	113	2	PS51259
Domain	Munc13_subgr_dom-2	UNC13C UNC13A	3.59e-04	5	113	2	IPR019558
Domain	Membr_traf_MHD	UNC13C UNC13A	3.59e-04	5	113	2	PF10540
Domain	DUF1041	UNC13C UNC13A	3.59e-04	5	113	2	SM01145
Domain	Ca_hom_mod	CALHM5 CALHM1	5.36e-04	6	113	2	PF14798
Domain	FAM26	CALHM5 CALHM1	5.36e-04	6	113	2	IPR029569
Domain	Ribosomal_S6_kinase_II	RPS6KA1 RPS6KA6	5.36e-04	6	113	2	IPR016239
Domain	Munc13_1	UNC13C UNC13A	7.47e-04	7	113	2	IPR014770
Domain	MHD1	UNC13C UNC13A	7.47e-04	7	113	2	PS51258
Domain	ZnF_UBR1	UBR4 UBR5	7.47e-04	7	113	2	SM00396
Domain	DUF1041	UNC13C UNC13A	7.47e-04	7	113	2	PF06292
Domain	CAPS_dom	UNC13C UNC13A	7.47e-04	7	113	2	IPR010439
Domain	NAD_binding_6	CYBB NOX1	7.47e-04	7	113	2	PF08030
Domain	ZF_UBR	UBR4 UBR5	7.47e-04	7	113	2	PS51157
Domain	FAD_binding_8	CYBB NOX1	7.47e-04	7	113	2	PF08022
Domain	zf-UBR	UBR4 UBR5	7.47e-04	7	113	2	PF02207
Domain	Znf_UBR	UBR4 UBR5	7.47e-04	7	113	2	IPR003126
Domain	FAD-bd_8	CYBB NOX1	7.47e-04	7	113	2	IPR013112
Domain	Fe_red_NAD-bd_6	CYBB NOX1	7.47e-04	7	113	2	IPR013121
Domain	Clathrin_mu	AP2M1 AP5M1	1.58e-03	10	113	2	IPR001392
Domain	-	EGF LRP2 ROS1	1.68e-03	39	113	3	2.120.10.30
Domain	Adap_comp_sub	AP2M1 AP5M1	1.93e-03	11	113	2	PF00928
Domain	Ferric_reduct	CYBB NOX1	2.30e-03	12	113	2	PF01794
Domain	Fe3_Rdtase_TM_dom	CYBB NOX1	2.30e-03	12	113	2	IPR013130
Domain	6-blade_b-propeller_TolB-like	EGF LRP2 ROS1	2.71e-03	46	113	3	IPR011042
Domain	MHD	AP2M1 AP5M1	2.71e-03	13	113	2	PS51072
Domain	MHD	AP2M1 AP5M1	2.71e-03	13	113	2	IPR028565
Domain	Ldl_recept_b	EGF LRP2	3.15e-03	14	113	2	PF00058
Domain	LDLRB	EGF LRP2	3.15e-03	14	113	2	PS51120
Domain	PI3/4_kinase_CS	PIK3C3 MTOR	3.62e-03	15	113	2	IPR018936
Domain	-	PIK3C3 MTOR	4.12e-03	16	113	2	1.10.1070.11
Domain	PI3Kc	PIK3C3 MTOR	4.12e-03	16	113	2	SM00146
Domain	TF_T-box	TBX15 TBX18	4.65e-03	17	113	2	IPR001699
Domain	TBOX	TBX15 TBX18	4.65e-03	17	113	2	SM00425
Domain	TF_T-box_CS	TBX15 TBX18	4.65e-03	17	113	2	IPR018186
Domain	-	TBX15 TBX18	4.65e-03	17	113	2	2.60.40.820
Domain	TBOX_3	TBX15 TBX18	4.65e-03	17	113	2	PS50252
Domain	T-box	TBX15 TBX18	4.65e-03	17	113	2	PF00907
Domain	TBOX_1	TBX15 TBX18	4.65e-03	17	113	2	PS01283
Domain	TBOX_2	TBX15 TBX18	4.65e-03	17	113	2	PS01264
Domain	PI3_PI4_kinase	PIK3C3 MTOR	5.21e-03	18	113	2	PF00454
Domain	PI3_4_KINASE_1	PIK3C3 MTOR	5.21e-03	18	113	2	PS00915
Domain	PI3_4_KINASE_2	PIK3C3 MTOR	5.21e-03	18	113	2	PS00916
Domain	PI3/4_kinase_cat_dom	PIK3C3 MTOR	5.21e-03	18	113	2	IPR000403
Domain	PI3_4_KINASE_3	PIK3C3 MTOR	5.21e-03	18	113	2	PS50290
Domain	Fd_Rdtase_FAD-bd	CYBB NOX1	5.80e-03	19	113	2	IPR017927
Domain	FAD_FR	CYBB NOX1	5.80e-03	19	113	2	PS51384
Domain	Riboflavin_synthase-like_b-brl	CYBB NOX1	5.80e-03	19	113	2	IPR017938
Pubmed	UBE2S interacting with TRIM21 mediates the K11-linked ubiquitination of LPP to promote the lymphatic metastasis of bladder cancer.	UBR4 UBR5 PRMT1 ZNF598	6.96e-07	21	117	4	37422473
Pubmed	Proteomic Analysis Reveals a Role for RSK in p120-catenin Phosphorylation and Melanoma Cell-Cell Adhesion.	DOCK4 RPS6KA1 KAT7 CLPTM1L AP2M1 SUDS3 RPS6KA6	1.24e-06	160	117	7	31678930
Pubmed	CUL3 (cullin 3)-mediated ubiquitination and degradation of BECN1 (beclin 1) inhibit autophagy and promote tumor progression.	BCL2 PIK3C3 RUBCN	2.05e-06	8	117	3	33977871
Pubmed	EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance.	BCL2 PIK3C3 RUBCN	3.07e-06	9	117	3	24034250
Pubmed	STYK1 promotes autophagy through enhancing the assembly of autophagy-specific class III phosphatidylinositol 3-kinase complex I.	BCL2 PIK3C3 RUBCN	4.38e-06	10	117	3	31696776
Pubmed	Receptor signaling lymphocyte-activation molecule family 1 (Slamf1) regulates membrane fusion and NADPH oxidase 2 (NOX2) activity by recruiting a Beclin-1/Vps34/ultraviolet radiation resistance-associated gene (UVRAG) complex.	CYBB PIK3C3 RUBCN	4.38e-06	10	117	3	22493499
Pubmed	mTORC1 phosphorylates UVRAG to negatively regulate autophagosome and endosome maturation.	PIK3C3 MTOR RUBCN	1.04e-05	13	117	3	25533187
Pubmed	Adverse cognitive effects of high-fat diet in a murine model of sleep apnea are mediated by NADPH oxidase activity.	CYBB NOX1	1.12e-05	2	117	2	23064009
Pubmed	NADPH oxidase and the degeneration of dopaminergic neurons in parkinsonian mice.	CYBB NOX1	1.12e-05	2	117	2	24379900
Pubmed	mTORC2-mediated direct phosphorylation regulates YAP activity promoting glioblastoma growth and invasive characteristics.	MTOR YAP1	1.12e-05	2	117	2	34343821
Pubmed	Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex.	MTOR YAP1	1.12e-05	2	117	2	25288394
Pubmed	PRMT1 potentiates chondrosarcoma development through activation of YAP activity.	YAP1 PRMT1	1.12e-05	2	117	2	31478263
Pubmed	The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice.	CYBB NOX1	1.12e-05	2	117	2	16877542
Pubmed	Silibinin Induced Human Glioblastoma Cell Apoptosis Concomitant with Autophagy through Simultaneous Inhibition of mTOR and YAP.	MTOR YAP1	1.12e-05	2	117	2	29780826
Pubmed	Redox modifier genes in amyotrophic lateral sclerosis in mice.	CYBB NOX1	1.12e-05	2	117	2	17853944
Pubmed	Hepatocyte growth factor and epidermal growth factor in HIV infected women with preeclampsia.	HGF EGF	1.12e-05	2	117	2	31202974
Pubmed	Evaluation of NADPH oxidases as drug targets in a mouse model of familial amyotrophic lateral sclerosis.	CYBB NOX1	1.12e-05	2	117	2	27212019
Pubmed	Agrin as a Mechanotransduction Signal Regulating YAP through the Hippo Pathway.	YAP1 AGRN	1.12e-05	2	117	2	28273460
Pubmed	KAT7 promoted gastric cancer progression through promoting YAP1 activation.	KAT7 YAP1	1.12e-05	2	117	2	35868058
Pubmed	Ethanol induces oxidative stress in alveolar macrophages via upregulation of NADPH oxidases.	CYBB NOX1	1.12e-05	2	117	2	22412195
Pubmed	Coordinated integrin and growth factor regulation of primary keratinocyte migration mediated through extracellular signal regulated kinase and phosphoinositide 3-kinase.	HGF EGF	1.12e-05	2	117	2	19330341
Pubmed	Differential Roles of the NADPH-Oxidase 1 and 2 in Platelet Activation and Thrombosis.	CYBB NOX1	1.12e-05	2	117	2	26988594
Pubmed	VEO-IBD NOX1 variant highlights a structural region essential for NOX/DUOX catalytic activity.	CYBB NOX1	1.12e-05	2	117	2	37820403
Pubmed	The role of Nox1 and Nox2 in GPVI-dependent platelet activation and thrombus formation.	CYBB NOX1	1.12e-05	2	117	2	24494191
Pubmed	Cerebral microvascular responses to hypercholesterolemia: roles of NADPH oxidase and P-selectin.	CYBB SELP	1.12e-05	2	117	2	14670846
Pubmed	Type I collagen reduces lipid accumulation during adipogenesis of preadipocytes 3T3-L1 via the YAP-mTOR-autophagy axis.	MTOR YAP1	1.12e-05	2	117	2	35595017
Pubmed	Sanguinarine-induced apoptosis: generation of ROS, down-regulation of Bcl-2, c-FLIP, and synergy with TRAIL.	BCL2 CFLAR	1.12e-05	2	117	2	18189268
Pubmed	Celastrol mediates autophagy and apoptosis via the ROS/JNK and Akt/mTOR signaling pathways in glioma cells.	MTOR ROS1	1.12e-05	2	117	2	31053160
Pubmed	LPA, HGF, and EGF utilize distinct combinations of signaling pathways to promote migration and invasion of MDA-MB-231 breast carcinoma cells.	HGF EGF	1.12e-05	2	117	2	24160245
Pubmed	Hepatocyte growth factor suppresses tumor cell apoptosis in nasopharyngeal carcinoma by upregulating Bcl-2 protein expression.	HGF BCL2	1.12e-05	2	117	2	19625133
Pubmed	The actions of exogenous leucine on mTOR signalling and amino acid transporters in human myotubes.	PIK3C3 MTOR	1.12e-05	2	117	2	21702994
Pubmed	Clinical value of serum hepatocyte growth factor, B-cell lymphoma-2 and nitric oxide in primary breast cancer patients.	HGF BCL2	1.12e-05	2	117	2	22953646
Pubmed	Netrin-1 abrogates ischemia/reperfusion-induced cardiac mitochondrial dysfunction via nitric oxide-dependent attenuation of NOX4 activation and recoupling of NOS.	CYBB NOX1	1.12e-05	2	117	2	25066694
Pubmed	Impulsivity and aggression in alcohol withdrawal syndrome is modulated by the interaction of ZNF804A and mTOR polymorphism.	ZNF804A MTOR	1.12e-05	2	117	2	38216065
Pubmed	Activation of NADPH oxidases leads to DNA damage in esophageal cells.	CYBB NOX1	1.12e-05	2	117	2	28855537
Pubmed	NADPH oxidase-1 plays a crucial role in hyperoxia-induced acute lung injury in mice.	CYBB NOX1	1.12e-05	2	117	2	19661248
Pubmed	Superoxide induced inhibition of death receptor signaling is mediated via induced expression of apoptosis inhibitory protein cFLIP.	BCL2 CFLAR	1.12e-05	2	117	2	31954371
Pubmed	Anaerobic Respiration of NOX1-Derived Hydrogen Peroxide Licenses Bacterial Growth at the Colonic Surface.	CYBB NOX1	1.12e-05	2	117	2	33301718
Pubmed	The involvement of the docking protein Gab1 in mitogenic signalling induced by EGF and HGF in rat hepatocytes.	HGF EGF	1.12e-05	2	117	2	24126105
Pubmed	Phosphorylated mTOR and YAP serve as prognostic markers and therapeutic targets in gliomas.	MTOR YAP1	1.12e-05	2	117	2	28759011
Pubmed	Endothelial NADPH oxidases: which NOX to target in vascular disease?	CYBB NOX1	1.12e-05	2	117	2	25066192
Pubmed	Branched-chain amino acids and arginine suppress MaFbx/atrogin-1 mRNA expression via mTOR pathway in C2C12 cell line.	MTOR FBXO32	1.12e-05	2	117	2	18616983
Pubmed	In the absence of reactive oxygen species, T cells default to a Th1 phenotype and mediate protection against pulmonary Cryptococcus neoformans infection.	CYBB NOX1	1.12e-05	2	117	2	17015737
Pubmed	The NADPH oxidase Nox2 regulates VEGFR1/CSF-1R-mediated microglial chemotaxis and promotes early postnatal infiltration of phagocytes in the subventricular zone of the mouse cerebral cortex.	CYBB NOX1	1.12e-05	2	117	2	23836548
Pubmed	NADPH Oxidases Are Essential for Macrophage Differentiation.	CYBB NOX1	1.12e-05	2	117	2	27489105
Pubmed	YAP accelerates vascular senescence via blocking autophagic flux and activating mTOR.	MTOR YAP1	1.12e-05	2	117	2	33314583
Pubmed	Inherited neuronal ion channelopathies: new windows on complex neurological diseases.	CACNA1A SCN1A	1.12e-05	2	117	2	19005038
Pubmed	Systematic Review: Models of Changes in Gene Expression of MTOR, MURF-1, and MAFBX in Rats and Mice.	MTOR FBXO32	1.12e-05	2	117	2	32421985
Pubmed	Lactucin induces apoptosis through reactive oxygen species-mediated BCL-2 and CFLARL downregulation in Caki-1 cells.	BCL2 CFLAR	1.12e-05	2	117	2	34302634
Pubmed	Bcl2 and ROS1 expression in human meningiomas: an analysis with respect to histological subtype.	BCL2 ROS1	1.12e-05	2	117	2	16761743
Pubmed	Thymoquinone induces apoptosis through downregulation of c-FLIP and Bcl-2 in renal carcinoma Caki cells.	BCL2 CFLAR	1.12e-05	2	117	2	27573448
Pubmed	Decreased blood pressure in NOX1-deficient mice.	CACNA1A NOX1	1.12e-05	2	117	2	16386251
Pubmed	LC3-Associated Phagocytosis in Myeloid Cells Promotes Tumor Immune Tolerance.	CYBB PIK3C3 RUBCN	1.64e-05	15	117	3	30245008
Pubmed	Akt/Nox2/NF-κB signaling pathway is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.	CYBB NOX1 PIK3C3	2.01e-05	16	117	3	21029719
Pubmed	Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.	DOCK4 USP37 PIK3C3 YAP1 PRMT1 FGD6 CPSF3	2.62e-05	255	117	7	15324660
Pubmed	Beclin 2 functions in autophagy, degradation of G protein-coupled receptors, and metabolism.	BCL2 PIK3C3 RUBCN	2.92e-05	18	117	3	23954414
Pubmed	NADPH oxidase NOX2 defines a new antagonistic role for reactive oxygen species and cAMP/PKA in the regulation of insulin secretion.	CYBB NOX1	3.36e-05	3	117	2	22933115
Pubmed	LKB1 tumor suppressor regulates AMP kinase/mTOR-independent cell growth and proliferation via the phosphorylation of Yap.	MTOR YAP1	3.36e-05	3	117	2	23027127
Pubmed	Co-treatment with hepatocyte growth factor and TGF-beta1 enhances migration of HaCaT cells through NADPH oxidase-dependent ROS generation.	HGF NOX1	3.36e-05	3	117	2	20177149
Pubmed	Systematic analysis of three FHM genes in 39 sporadic patients with hemiplegic migraine.	CACNA1A SCN1A	3.36e-05	3	117	2	18056581
Pubmed	Munc13-3 Is Required for the Developmental Localization of Ca2+ Channels to Active Zones and the Nanopositioning of Cav2.1 Near Release Sensors.	CACNA1A UNC13C	3.36e-05	3	117	2	29466725
Pubmed	Development of an improved and specific inhibitor of NADPH oxidase 2 to treat traumatic brain injury.	CYBB NOX1	3.36e-05	3	117	2	36709665
Pubmed	Role of Nox isoforms in angiotensin II-induced oxidative stress and endothelial dysfunction in brain.	CYBB NOX1	3.36e-05	3	117	2	22628375
Pubmed	Migration induced by epidermal and hepatocyte growth factors in oral squamous carcinoma cells in vitro: role of MEK/ERK, p38 and PI-3 kinase/Akt.	HGF EGF	3.36e-05	3	117	2	22413835
Pubmed	A point mutation in the gene for asparagine-linked glycosylation 10B (Alg10b) causes nonsyndromic hearing impairment in mice (Mus musculus).	ALG10B ALG10	3.36e-05	3	117	2	24303013
Pubmed	Amyloid β-induced astrogliosis is mediated by β1-integrin via NADPH oxidase 2 in Alzheimer's disease.	CYBB NOX1	3.36e-05	3	117	2	27709751
Pubmed	Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy.	BCL2 PIK3C3	3.36e-05	3	117	2	16179260
Pubmed	The NADPH Oxidase Nox2 Mediates Vitamin D-Induced Vascular Regeneration in Male Mice.	CYBB NOX1	3.36e-05	3	117	2	27399878
Pubmed	NADPH oxidase-dependent generation of lysophosphatidylserine enhances clearance of activated and dying neutrophils via G2A.	CYBB NOX1	3.36e-05	3	117	2	18824544
Pubmed	Perturbation of ubiquitin homeostasis promotes macrophage oxidative defenses.	CYBB NOX1	3.36e-05	3	117	2	31308397
Pubmed	Genetic deletion of Nox4 enhances cancerogen-induced formation of solid tumors.	CYBB NOX1	3.36e-05	3	117	2	33836590
Pubmed	Insulin activation of vacuolar protein sorting 34 mediates localized phosphatidylinositol 3-phosphate production at lamellipodia and activation of mTOR/S6K1.	PIK3C3 MTOR	3.36e-05	3	117	2	24582588
Pubmed	NADPH Oxidase and Guanylate Binding Protein 5 Restrict Survival of Avirulent Type III Strains of Toxoplasma gondii in Naive Macrophages.	CYBB NOX1	3.36e-05	3	117	2	30154263
Pubmed	Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration.	CYBB NOX1	3.36e-05	3	117	2	20877715
Pubmed	Familial Hemiplegic Migraine	CACNA1A SCN1A	3.36e-05	3	117	2	20301562
Pubmed	Up-regulation of miR-497 confers resistance to temozolomide in human glioma cells by targeting mTOR/Bcl-2.	BCL2 MTOR	3.36e-05	3	117	2	28064447
Pubmed	Antimycin A sensitizes cells to TRAIL-induced apoptosis through upregulation of DR5 and downregulation of c-FLIP and Bcl-2.	BCL2 CFLAR	3.36e-05	3	117	2	22842544
Pubmed	Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase.	CYBB NOX1	3.36e-05	3	117	2	22456182
Pubmed	mTOR regulates PRMT1 expression and mitochondrial mass through STAT1 phosphorylation in hepatic cell.	MTOR PRMT1	3.36e-05	3	117	2	33741434
Pubmed	Smad3 induces atrogin-1, inhibits mTOR and protein synthesis, and promotes muscle atrophy in vivo.	MTOR FBXO32	3.36e-05	3	117	2	24002653
Pubmed	A constitutive NADPH oxidase-like system containing gp91phox homologs in human keratinocytes.	CYBB NOX1	3.36e-05	3	117	2	15102091
Pubmed	The contribution of CACNA1A, ATP1A2 and SCN1A mutations in hemiplegic migraine: A clinical and genetic study in Finnish migraine families.	CACNA1A SCN1A	3.36e-05	3	117	2	29486580
Pubmed	NADPH oxidase restrains the matrix metalloproteinase activity of macrophages.	CYBB NOX1	3.36e-05	3	117	2	15983040
Pubmed	Heterogeneous Presynaptic Distribution of Munc13 Isoforms at Retinal Synapses and Identification of an Unconventional Bipolar Cell Type with Dual Expression of Munc13 Isoforms: A Study Using Munc13-EXFP Knock-in Mice.	UNC13C UNC13A	3.36e-05	3	117	2	33105896
Pubmed	UBR E3 ligases and the PDIA3 protease control degradation of unfolded antibody heavy chain by ERAD.	UBR4 UBR5	3.36e-05	3	117	2	32558906
Pubmed	Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase.	RPS6KA1 MTOR	3.36e-05	3	117	2	15905173
Pubmed	PROX1 induction by autolysosomal activity stabilizes persister-like state of colon cancer via feedback repression of the NOX1-mTORC1 pathway.	NOX1 MTOR	3.36e-05	3	117	2	37224811
Pubmed	Light-emitting diode irradiation induces AKT/mTOR-mediated apoptosis in human pancreatic cancer cells and xenograft mouse model.	BCL2 MTOR	3.36e-05	3	117	2	32749680
Pubmed	Intrarenal artery superoxide is mainly NADPH oxidase-derived and modulates endothelium-dependent dilation in elderly patients.	CYBB NOX1	3.36e-05	3	117	2	19843513
Pubmed	Evaluation of apoptosis and angiogenesis in ectopic and eutopic stromal cells of patients with endometriosis compared to non-endometriotic controls.	HGF BCL2	3.36e-05	3	117	2	31906916
Pubmed	The Munc13 proteins differentially regulate readily releasable pool dynamics and calcium-dependent recovery at a central synapse.	UNC13C UNC13A	3.36e-05	3	117	2	23658173
Pubmed	Receptor activator of nuclear factor-kappaB ligand-induced mouse osteoclast differentiation is associated with switching between NADPH oxidase homologues.	CYBB NOX1	3.36e-05	3	117	2	19409483
Pubmed	Gp91phox NADPH oxidase modulates litter size by regulating mucin1 in the uterus of mice.	CYBB NOX1	3.36e-05	3	117	2	28301257
Pubmed	Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair.	CYBB NOX1	3.36e-05	3	117	2	23241962
Pubmed	SNP analyses of growth factor genes EGF, TGFbeta-1, and HGF reveal haplotypic association of EGF with autism.	HGF EGF	3.36e-05	3	117	2	17626784
Pubmed	Endosomal NADPH oxidase regulates c-Src activation following hypoxia/reoxygenation injury.	CYBB NOX1	3.36e-05	3	117	2	18397177
Pubmed	Lysosome trafficking is necessary for EGF-driven invasion and is regulated by p38 MAPK and Na+/H+ exchangers.	HGF EGF	3.36e-05	3	117	2	28978320
Pubmed	Varying effects of EGF, HGF and TGFβ on formation of invadopodia and invasiveness of melanoma cell lines of different origin.	HGF EGF	3.36e-05	3	117	2	28076931
Pubmed	Differential regulation of myosin X movements by its cargos, DCC and neogenin.	MYO10 NEO1	3.36e-05	3	117	2	22349703
Pubmed	Lysosomal-mediated waste clearance in retinal pigment epithelial cells is regulated by CRYBA1/βA3/A1-crystallin via V-ATPase-MTORC1 signaling.	ATP6V0A1 MTOR	3.36e-05	3	117	2	24468901
Cytoband	6q22	ROS1 DSE	1.79e-04	8	117	2	6q22
Cytoband	12q12	ALG10B ANO6 TMEM117	2.41e-04	47	117	3	12q12
Cytoband	Ensembl 112 genes in cytogenetic band chr6q22	CALHM5 HS3ST5 ROS1 DSE	3.25e-04	127	117	4	chr6q22
Cytoband	Ensembl 112 genes in cytogenetic band chr12q12	ALG10B ANO6 TMEM117	5.73e-04	63	117	3	chr12q12
GeneFamily	Alpha-1,2-glucosyltransferases	ALG10B ALG10	1.48e-05	2	70	2	448
GeneFamily	UNC13 homologs	UNC13C UNC13A	8.82e-05	4	70	2	836
GeneFamily	Ubiquitin protein ligase E3 component n-recognins	UBR4 UBR5	3.06e-04	7	70	2	785
GeneFamily	Mitogen-activated protein kinase-activated protein kinases	RPS6KA1 RPS6KA6	7.95e-04	11	70	2	1156
GeneFamily	T-boxes	TBX15 TBX18	2.17e-03	18	70	2	766
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B0\|367C / Donor, Lineage, Cell class and subclass (all cells)	NUP107 BCL2 DPP8 KAT7 SUPT7L GAN	2.76e-06	149	117	6	41f28138bde45d0b814e116837e5a32b5e80d54a
ToppCell	COVID-19-Heart-CM_5_(RYR2-)\|Heart / Disease (COVID-19 only), tissue and cell type	TBX15 NEB EGF UNC13C ROS1 FBXO32	3.46e-06	155	117	6	d7e26696fd9c0a759524f331243db43059b33ed9
ToppCell	normal_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th\|normal_Lung / Location, Cell class and cell subclass	CACNA1A NUP107 GSDMB C1GALT1 SPON1 NOCT	5.14e-06	166	117	6	ff32422390852546e0cb216192452e9c47bd9509
ToppCell	CV-Healthy-7\|CV / Virus stimulation, Condition and Cluster	STT3A ALG10B PHKB ALG10 GAN MICAL3	9.26e-06	184	117	6	0e5cc77aaa73ceb791f8be7456177577fd2e5586
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CYBB DOCK4 PLBD1 FAM20C CD180 DSE	9.55e-06	185	117	6	7bff05d8d34616adbaa0ea0b69eb30aa906bb9f8
ToppCell	CV-Healthy-7\|Healthy / Virus stimulation, Condition and Cluster	STT3A ALG10B PHKB ALG10 GAN MICAL3	9.55e-06	185	117	6	1979d189c204f4c2893e3170a514ee7d5523406c
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	DOCK4 GRIA3 NEO1 SPON1 UGGT2 MICAL3	1.14e-05	191	117	6	3379d145d34f89150f7b06d1340022cfc6b4a6ce
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-plasma_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBX15 ATP6V0A1 ENPP1 STT3A CLPTM1L SPON1	1.18e-05	192	117	6	6417468829517a0f6e04e7e44eec1622001d4c5c
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PLBD1 MRPS27 GATM FAM20C FGD6	1.28e-05	114	117	5	84318a25a701331ccd5e68221239c543b9c0cc54
ToppCell	Monocytes-M2-like_CD16+_macrophages\|World / Immune cells in Kidney/Urine in Lupus Nephritis	CYBB DOCK4 HGF CNRIP1 FGD6 DSE	1.29e-05	195	117	6	10fa47bdcf6c9784ea930b75a5861e139421feed
ToppCell	10x5'-GI_small-bowel-Myeloid_Mac-Erythrophagocytic_macrophages\|GI_small-bowel / Manually curated celltypes from each tissue	CYBB SIGLEC12 PLBD1 GATM CNRIP1 FAM20C	1.36e-05	197	117	6	be9879e3352b8c17e91ab1e2d1fb4c30ef6d8ce8
ToppCell	BAL-Mild-Myeloid-MoAM\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DOCK4 HGF DYSF FAM20C CD180 DSE	1.36e-05	197	117	6	0f40dd3530eb8d02e79b32f942efe3b65b8f6ee6
ToppCell	BAL-Mild-Myeloid-MoAM\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	DOCK4 HGF DYSF FAM20C CD180 DSE	1.36e-05	197	117	6	a6aa5991d566c28440f7e24a30933e69669064f2
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CYBB PLBD1 DYSF FAM20C MGST2 DSE	1.40e-05	198	117	6	579a22199643440b98e381147779ced630d4ed66
ToppCell	AT2_cells-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	CFLAR YAP1 SCN1A LRP2 ROS1 MLPH	1.40e-05	198	117	6	893036558a9ad86b57f9e735df35812e9d18739e
ToppCell	NS-critical-d_0-4-Myeloid\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CYBB DOCK4 LILRA3 CFLAR DSE FERMT3	1.40e-05	198	117	6	72d51284d267f102c26f0ae8279ee9e11e69c7e3
ToppCell	moderate-Myeloid-Non-resident_Macrophage\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CYBB DOCK4 LILRA3 FAM20C DSE FERMT3	1.44e-05	199	117	6	614c1e788d89310e78984241977941beed8d12dc
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast-FB-2\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	ENTHD1 GRIA3 SPON1 MICAL3 BBOX1	2.00e-05	125	117	5	6cd741dd1c7ee6b16437cca7c15c99b5c95603fc
ToppCell	PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CYBB HGF PLBD1 LILRA3 DSE	3.10e-05	137	117	5	12caa8ed7cc9e7a0f78c14ad5efe2fc28c3ce9be
ToppCell	COVID-19-Heart-CM_5_(RYR2-)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TBX15 NEB EGF UNC13C FBXO32	3.93e-05	144	117	5	f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf
ToppCell	10x5'-bone_marrow-Myeloid_Monocytic-Cycling_mono\|bone_marrow / Manually curated celltypes from each tissue	CYBB PLBD1 ATP6V0A1 DYSF FAM20C	4.48e-05	148	117	5	de35eeefad0e27a0d127e2e4bedead2bddb75152
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRINP3 MYO10 FAM20C LRP2 ROS1	4.93e-05	151	117	5	f4f7156b2c0cfc78fd1841e07c9915d97ced561f
ToppCell	PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ST6GALNAC1 RPS6KA1 NEB NOX1 AP5M1	6.49e-05	160	117	5	8308ca6f37986c526432a0fbc5f7ec2e75cfb6d7
ToppCell	5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EECs\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA1A CPT1B FAM153B ROS1 UNC13A	7.51e-05	165	117	5	4b4e75ad0eb0a6b00c30a000ec6267e23ba2e496
ToppCell	facs-Trachea-nan-18m-Myeloid-macrophage\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB PLBD1 GATM CD180 FERMT3	8.41e-05	169	117	5	c6ae131f0bfb757541322691311139fae8bdca21
ToppCell	facs-Trachea-nan-18m-Myeloid-nan\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB PLBD1 GATM CD180 FERMT3	8.65e-05	170	117	5	774b0c1b453e19651f9481dc6bcabac538c5acb7
ToppCell	droplet-Thymus-nan-21m-Myeloid-B_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB PLBD1 GATM SPON1 SLC25A19	8.89e-05	171	117	5	8bed33f61f7d12a1ac4fba33f730d839f5ee7bef
ToppCell	facs-Trachea-nan-18m-Myeloid\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB PLBD1 GATM CD180 FERMT3	8.89e-05	171	117	5	9d496a6edac9663791cda684188d49895246f6fe
ToppCell	COVID-19-Heart-T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1A NEB KLRF1 UNC13C UNC13A	8.89e-05	171	117	5	b2e753e811a7639956994609f73efcdb62d04f82
ToppCell	droplet-Liver-Hepatocytes-21m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB DYSF ANO6 AP5M1 DSE	9.13e-05	172	117	5	574ebdf36e45222bcd907cd2c2ee7ff50ed4573a
ToppCell	normal_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th\|T/NK_cells / Location, Cell class and cell subclass	CACNA1A NUP107 GSDMB SPON1 NOCT	9.13e-05	172	117	5	0657c736f3c52d25cf7f652eac005ddcde9232ef
ToppCell	MS-CD8-proli_CD4\|MS / Condition, Cell_class and T cell subcluster	RWDD2B FAM200A ADCY9 C3orf33 MICAL3	9.13e-05	172	117	5	0b6dd257110b3f17fa71ab18a165b091a9d5ae9a
ToppCell	droplet-Marrow-nan-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB HGF PLBD1 MGST2 PNPLA8	9.13e-05	172	117	5	d354424c1f861b6607dfd63b9724f4c237b30275
ToppCell	droplet-Liver-Hepatocytes-21m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB DYSF ANO6 AP5M1 DSE	9.13e-05	172	117	5	1627fa7035b0e0bbc82a1c0f000d8231254c680a
ToppCell	facs-Heart-RA-3m-Myeloid-monocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB PLBD1 RPS6KA1 GATM FERMT3	9.39e-05	173	117	5	4fa5f502fa3ff8f888e279f68a0dafd91b37f26f
ToppCell	facs-Heart-RA-3m-Myeloid\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB PLBD1 RPS6KA1 GATM FERMT3	9.39e-05	173	117	5	5058cb5e3f2d57dbe947e1b113eb2bef7bf6dd7d
ToppCell	facs-Heart-RA-3m-Myeloid-monocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB PLBD1 RPS6KA1 GATM FERMT3	9.39e-05	173	117	5	ea406b47ff3ead992bc06f6b1707c76eee574782
ToppCell	10x5'-bone_marrow-Myeloid_Mac-Intestinal_macrophages\|bone_marrow / Manually curated celltypes from each tissue	DOCK4 GATM ZNF804A FAM20C FGD6	9.64e-05	174	117	5	0746344d62aa7ab77c378e9d5a9f9238e741a76b
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1A PLBD1 GRIA3 ALG10B SLC25A19	9.64e-05	174	117	5	ff13a5c55d18b951315908f33cb47c7f9cb901bf
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLBD1 GATM MTOR GAN SLC25A19	9.91e-05	175	117	5	bb058e714d21a0ec8532eaf3c7dd2faf78016bc0
ToppCell	droplet-Heart-nan-3m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GATM GRIA3 MTOR GAN MLPH	1.13e-04	180	117	5	da723df348d7b8449bb1124f23fe6fa706412adb
ToppCell	droplet-Limb_Muscle-Pre-Sort\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SELP TMEM250 GATM MORF4L1 LRP2	1.13e-04	180	117	5	af2bafcd1b2082629de3ea336711add01565c4c4
ToppCell	facs-Lung-EPCAM-3m-Myeloid-Dendritic_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY9 NEO1 SPON1 MICAL3 CPSF3	1.13e-04	180	117	5	710526abedc8e0f9ba19ad69220df4c9468ada8f
ToppCell	droplet-Heart-nan-3m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GATM GRIA3 MTOR GAN MLPH	1.13e-04	180	117	5	5b146a94708b3c3610542a4d0925f3f7a2b19185
ToppCell	droplet-Heart-nan-3m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GATM GRIA3 MTOR GAN MLPH	1.13e-04	180	117	5	50758b1e7be2e43f83c10ab106900c067e61f5f7
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SELP TMEM250 GATM MORF4L1 LRP2	1.13e-04	180	117	5	f29a995cf6e1a1836ed68b73258d9370bf3d4434
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYBB ZNF695 NEB ZNF804A DSE	1.19e-04	182	117	5	4234d0cc57b5266a5e03133c75c7918abe48465e
ToppCell	LPS_only-Myeloid\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CYBB PLBD1 LILRA3 CFLAR FERMT3	1.19e-04	182	117	5	666ac86ee5f6fa9241ae8d80340743707e54b278
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	EGF SCN1A LRP2 ROS1 MLPH	1.25e-04	184	117	5	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B0\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	NUP107 DPP8 KAT7 SUPT7L GAN	1.32e-04	186	117	5	74c238759c5d3fd39127ec0060d0c2cb16b326d4
ToppCell	368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DOCK4 GSDMB HS3ST5 FBXO32 RUBCN	1.32e-04	186	117	5	77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BCL2 MYO3A SPON1 LRP2 MICAL3	1.32e-04	186	117	5	f28d72b47624b69a580b4429e2be560a26898591
ToppCell	368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DOCK4 GSDMB HS3ST5 FBXO32 RUBCN	1.32e-04	186	117	5	13bc41c60fd628af31899a5e8b480e06cc4781be
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GATM ADCY9 FAM20C LRP2 BBOX1	1.35e-04	187	117	5	3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D231\|Adult / Lineage, Cell type, age group and donor	YAP1 SCN1A LRP2 ROS1 MLPH	1.42e-04	189	117	5	dab54a52358f66a8a9460cd6089a06c5fa7e7a5d
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	DOCK4 GRIA3 NEO1 SPON1 UGGT2	1.42e-04	189	117	5	dc5164591dea45b420798b94dda211be03daa70c
ToppCell	BAL-Control-Myeloid-MoAM-MoAM1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DOCK4 HGF DYSF UNC13C CD180	1.42e-04	189	117	5	ebb5e069fdca7cf8ffac16a57572e92d2593c86a
ToppCell	BAL-Control-Myeloid-MoAM-MoAM1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DOCK4 HGF DYSF UNC13C CD180	1.42e-04	189	117	5	a59e4eaff430a443f9fa7edabe64e66a15b6bffb
ToppCell	BAL-Control-Myeloid-MoAM-MoAM1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DOCK4 HGF DYSF UNC13C CD180	1.46e-04	190	117	5	5c8aa310886c64ee5dce4ba46a3dd178da549529
ToppCell	PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	DOCK4 GRIA3 NEO1 SPON1 UGGT2	1.46e-04	190	117	5	1196b8ea2c44c7c80f5ee589dd517e6a413f2077
ToppCell	tumor_Lung-Fibroblasts-Mesothelial_cells\|Fibroblasts / Location, Cell class and cell subclass	C1GALT1 TBX18 FAM153B LRP2 AGRN	1.46e-04	190	117	5	d82ab67735c1f365d4b0e02b5fa91c64cdc234da
ToppCell	renal_medulla_nuclei-Adult_normal_reference\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK4 MYO10 CFLAR EGF UNC13C	1.46e-04	190	117	5	f1363f7806cfc4f14fbc1b0e8dac2de813a88eee
ToppCell	BAL-Control-Myeloid-MoAM-MoAM1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DOCK4 HGF DYSF UNC13C CD180	1.46e-04	190	117	5	4b4fe93061c87605dddf5bec94fa07c749c722aa
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-MMP9+_Inflammatory_macrophage\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYBB SIGLEC12 GATM CD180 FERMT3	1.49e-04	191	117	5	87b974a320888d63aa8cefcd8dc97d525b56d848
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CACNA1A MYO10 BCL2 EEF1B2 RPS6KA6	1.53e-04	192	117	5	32927ef3b93e0497e9bbe63c2754da03cf178202
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	BRINP3 GRIA3 SPON1 UNC13C FBXO32	1.53e-04	192	117	5	72881b280a415e65f87a80ca1369cbb0b722a0c4
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	YAP1 SCN1A LRP2 ROS1 MLPH	1.53e-04	192	117	5	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	YAP1 SCN1A LRP2 ROS1 MLPH	1.57e-04	193	117	5	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CYBB PLBD1 DYSF MGST2 DSE	1.57e-04	193	117	5	52f5b0fbb8ca706206c65e7edbb1ddbd380aebae
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2\|Adult / Lineage, Cell type, age group and donor	YAP1 SCN1A LRP2 ROS1 MLPH	1.57e-04	193	117	5	738f4f0a9ddde2432b429ab46838e353b1790589
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	YAP1 SCN1A LRP2 ROS1 MLPH	1.57e-04	193	117	5	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MYO10 RWDD2B UBR5 SLC25A19 SLC25A17	1.60e-04	194	117	5	8f4b63b0b9a40765205e4ca6bd94a675a83dbe3d
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	YAP1 SCN1A LRP2 ROS1 MLPH	1.64e-04	195	117	5	6617abca0009ad3d8731f515f91ab275f9ea4c40
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	YAP1 SCN1A LRP2 ROS1 MLPH	1.64e-04	195	117	5	fc0ae145a2118df7cbbc9ac4ca9dc12d26c087c4
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	HGF MYO10 NEO1 SPON1 UNC13C	1.64e-04	195	117	5	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	YAP1 SCN1A LRP2 ROS1 MLPH	1.64e-04	195	117	5	d9694db6bf239636d1335016878c98f6ee2eb0eb
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ENPP1 ADCY9 MGST2 RPS6KA6 RUBCN	1.64e-04	195	117	5	d8fa96c8f14bd088c3f8bd14f894a2c5b7ad46a7
ToppCell	10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	CYBB PLBD1 DYSF CFLAR NEO1	1.64e-04	195	117	5	fb3dc2c8fd125f23d0c3aa211520778aac8d6dda
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	YAP1 SCN1A LRP2 ROS1 MLPH	1.68e-04	196	117	5	82b117be41f2e7d677a42d2a5198726eeccb16d0
ToppCell	COVID-19_Mild-Classical_Monocyte-cMono_3\|Classical_Monocyte / Disease condition and Cell class	CYBB PLBD1 LILRA3 DYSF RUBCN	1.68e-04	196	117	5	15397ec27167bb2fb6fec120b68bf38fc71b2670
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	DOCK4 GRIA3 NEO1 SPON1 MICAL3	1.68e-04	196	117	5	54f4cf778f95a9ff662e5c7520916a25e605bf95
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM1\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	DOCK4 HGF DYSF FAM20C CD180	1.68e-04	196	117	5	7c8aa5853d7096628e35af665097c0299c329753
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYBB CFLAR PNPLA8 SLC25A19 DSE	1.68e-04	196	117	5	01cea0bb0b938d0986fd2ddae06597b8af1768ee
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM1-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DOCK4 HGF DYSF FAM20C CD180	1.68e-04	196	117	5	f60b220ed117bcc33e0f7bbf5b53d3b1422ebaca
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM1-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DOCK4 HGF DYSF FAM20C CD180	1.68e-04	196	117	5	bcd274db4955ea76ca26267a272c7d1929db24f4
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM1\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DOCK4 HGF DYSF FAM20C CD180	1.68e-04	196	117	5	80b9139d91dda4de69830d2d443859e047ab5503
ToppCell	Mild_COVID-19-Myeloid-MoAM1\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	DOCK4 HGF DYSF FAM20C CD180	1.68e-04	196	117	5	ea3fbe81b4ecb6ccc8031f6d99da93c9f9f8c1aa
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BCL2 NEB ZNF804A EDDM3A MICAL3	1.68e-04	196	117	5	de43dd0697e1daf4d50800957cf0b27b54a7a333
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CYBB DOCK4 RPS6KA1 MGST2 DSE	1.68e-04	196	117	5	e54c08f88779f9fd453a4f5b85aed1f460d8a1e1
ToppCell	10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-neutrophil\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	CYBB PLBD1 DYSF CFLAR NEO1	1.72e-04	197	117	5	8dd10962b6ba587512b2e68c762ade68c751cbc8
ToppCell	5'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MLXIP NEO1 NOX1 SPON1 MLPH	1.72e-04	197	117	5	e14a0e8a893c72356afc5508e3531ae0b23bfe16
ToppCell	VE-mDC2-\|VE / Condition, Cell_class and T cell subcluster	CYBB PLBD1 MGST2 CD180 DSE	1.72e-04	197	117	5	6629588819ec31a7e4f33b94b8c035145a5f6c17
ToppCell	URO-Myeloid-cDC2\|URO / Disease, Lineage and Cell Type	GATM MGST2 MORF4L1 PRMT1 CD180	1.72e-04	197	117	5	7fee14356d7fba68a0515c8b9284568d14124b0a
ToppCell	5'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MLXIP NEO1 NOX1 SPON1 MLPH	1.72e-04	197	117	5	19cf283537c853fa902852e7b8ac1139729a931a
ToppCell	VE-mDC2\|VE / Condition, Cell_class and T cell subcluster	CYBB PLBD1 MGST2 CD180 DSE	1.72e-04	197	117	5	e3172102ad17c92c3038cad37bf933eb04351048
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	YAP1 SCN1A LRP2 ROS1 MLPH	1.76e-04	198	117	5	f948391296c261c473d339069a6d0f20ccd6f38f
ToppCell	10x5'-GI_small-bowel-Myeloid_Mac\|GI_small-bowel / Manually curated celltypes from each tissue	CYBB PLBD1 GATM CNRIP1 FAM20C	1.76e-04	198	117	5	748db69d3c9774e44c0cc425d937d18b83af8312
ToppCell	5'-Adult-Distal_Rectal-Epithelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MLXIP NEO1 NOX1 SPON1 MLPH	1.76e-04	198	117	5	9c0535099750698daac5d6b4d39fb19fecf4ffde
ToppCell	NS-moderate-d_16-33-Myeloid-Non-resident_Macrophage\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CYBB LILRA3 FAM20C DSE FERMT3	1.76e-04	198	117	5	11a7a553de6786c1e8288251ba0d5c898505c158
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CYBB SIGLEC12 PNPLA8 DSE FERMT3	1.76e-04	198	117	5	3a1707318814dabdec48f91fa6bd223f5b879653
Disease	lung adenocarcinoma (is_implicated_in)	CHD4 CLPTM1L EGF UBR5	3.65e-05	49	112	4	DOID:3910 (is_implicated_in)
Disease	Long Qt Syndrome 2	ALG10B ALG10	4.27e-05	3	112	2	C3150943
Disease	Familial or sporadic hemiplegic migraine	CACNA1A SCN1A	4.27e-05	3	112	2	cv:CN295307
Disease	Familial hemiplegic migraine	CACNA1A SCN1A	4.27e-05	3	112	2	cv:C0338484
Disease	Coffin-Lowry syndrome (implicated_via_orthology)	RPS6KA1 RPS6KA6	8.53e-05	4	112	2	DOID:3783 (implicated_via_orthology)
Disease	Metaplasia	BCL2 EGF	1.42e-04	5	112	2	C0025568
Disease	gallbladder carcinoma (is_implicated_in)	CLPTM1L UBR5	1.42e-04	5	112	2	DOID:4948 (is_implicated_in)
Disease	childhood absence epilepsy (implicated_via_orthology)	CACNA1A NPY5R	2.12e-04	6	112	2	DOID:1825 (implicated_via_orthology)
Disease	nonsyndromic deafness (implicated_via_orthology)	ALG10B ALG10	2.12e-04	6	112	2	DOID:0050563 (implicated_via_orthology)
Disease	Hirsutism	TBX15 BCL2	2.12e-04	6	112	2	HP_0001007
Disease	Large cell carcinoma of lung	MTOR RPS6KA6 ROS1	2.44e-04	32	112	3	C0345958
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	ZNF804A MYO3A MTOR AP5M1 RNF139	2.59e-04	148	112	5	C0279702
Disease	muscular atrophy (implicated_via_orthology)	MTOR FBXO32	2.96e-04	7	112	2	DOID:767 (implicated_via_orthology)
Disease	Kidney Diseases	CYBB GATM EGF LRP2	3.59e-04	88	112	4	C0022658
Disease	Reperfusion Injury	CYBB HGF BCL2 EGF	3.75e-04	89	112	4	C0035126
Disease	tongue squamous cell carcinoma (is_marker_for)	HGF BRINP3 BCL2	3.76e-04	37	112	3	DOID:0050865 (is_marker_for)
Disease	retinal degeneration (is_implicated_in)	HGF BCL2	5.05e-04	9	112	2	DOID:8466 (is_implicated_in)
Disease	transverse temporal cortex volume measurement	HGF UNC13C	6.30e-04	10	112	2	EFO_0010336
Disease	Myoclonic Astatic Epilepsy	AP2M1 SCN1A	7.68e-04	11	112	2	C0393702
Disease	acute myeloid leukemia (is_marker_for)	BCL2 CFLAR FERMT3	8.64e-04	49	112	3	DOID:9119 (is_marker_for)
Disease	Fetal Alcohol Spectrum Disorders	RPS6KA1 BCL2	1.08e-03	13	112	2	C2985290
Disease	chronic lymphocytic leukemia	ENPP1 BCL2 CFLAR CLPTM1L	1.12e-03	119	112	4	EFO_0000095
Disease	benign prostatic hyperplasia	NUP107 UNC13A	1.26e-03	14	112	2	EFO_0000284
Disease	Proteinuria	LRP2 UNC13C	1.45e-03	15	112	2	HP_0000093
Disease	Sarcomatoid Renal Cell Carcinoma	ZNF804A MTOR AP5M1 RNF139	1.46e-03	128	112	4	C1266043
Disease	Chromophobe Renal Cell Carcinoma	ZNF804A MTOR AP5M1 RNF139	1.46e-03	128	112	4	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	ZNF804A MTOR AP5M1 RNF139	1.46e-03	128	112	4	C1266044
Disease	Papillary Renal Cell Carcinoma	ZNF804A MTOR AP5M1 RNF139	1.46e-03	128	112	4	C1306837
Disease	Renal Cell Carcinoma	ZNF804A MTOR AP5M1 RNF139	1.46e-03	128	112	4	C0007134
Disease	acute kidney failure (biomarker_via_orthology)	GATM BCL2 EGF	1.63e-03	61	112	3	DOID:3021 (biomarker_via_orthology)
Disease	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	UBR5 MTOR	1.65e-03	16	112	2	C0334634
Disease	body mass index, type 2 diabetes mellitus	BCL2 MTOR	1.65e-03	16	112	2	EFO_0004340, MONDO_0005148
Disease	partial epilepsy	ADCY9 SCN1A	1.87e-03	17	112	2	EFO_0004263
Disease	Fetal Alcohol Syndrome	RPS6KA1 BCL2	1.87e-03	17	112	2	C0015923
Disease	nephrotic syndrome	GSDMB MORF4L1 DSE	2.52e-03	71	112	3	EFO_0004255
Disease	atherosclerosis (biomarker_via_orthology)	SELP BCL2	2.59e-03	20	112	2	DOID:1936 (biomarker_via_orthology)
Disease	end stage renal disease (implicated_via_orthology)	BCL2 MTOR	2.59e-03	20	112	2	DOID:783 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	UBR4 GSDMB BCL2 DYSF PHKB CLPTM1L EEF1B2 EGF MTOR YAP1 CPSF3	2.60e-03	1074	112	11	C0006142
Disease	status epilepticus (implicated_via_orthology)	BCL2 MTOR	2.86e-03	21	112	2	DOID:1824 (implicated_via_orthology)
Disease	behavioural disinhibition measurement	ENTHD1 RXYLT1 UNC13C	2.95e-03	75	112	3	EFO_0006946
Disease	Non-Small Cell Lung Carcinoma	PLBD1 CLPTM1L MTOR ROS1	3.00e-03	156	112	4	C0007131
Disease	mean reticulocyte volume	RPS6KA1 BCL2 CHD4 MLXIP DPP8 NEB ADCY9 KAT7 MTOR	3.45e-03	799	112	9	EFO_0010701
Disease	epilepsy (implicated_via_orthology)	CACNA1A SCN1A UNC13C UNC13A	3.51e-03	163	112	4	DOID:1826 (implicated_via_orthology)
Disease	pulmonary hypertension (biomarker_via_orthology)	CYBB BCL2 NOX1	3.54e-03	80	112	3	DOID:6432 (biomarker_via_orthology)
Disease	congestive heart failure (is_marker_for)	GATM CFLAR MTOR	3.79e-03	82	112	3	DOID:6000 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
LHFKVKWLYNEYVTE	UNC13A	1116	Q9UPW8
KKYEFHYDNVLWALL	CACNA1A	1436	O00555
NNIYWREFIKLHYLS	EDDM3A	26	Q14507
NKWKTFFETVHIYLR	BRINP3	616	Q76B58
THATKAIYRWLLSDY	CPSF3	96	Q9UKF6
YKFWSQISQGHLSYK	GSDMB	176	Q8TAX9
QHTYSCKVRVWRYLK	AGRN	61	O00468
QAAFLKSKYWSHYID	CALHM1	211	Q8IU99
KSKYWSHYIDIERKL	CALHM1	216	Q8IU99
LVWKFTYAHKYLLAD	ALG10B	336	Q5I7T1
LFFAVKYLLRWKYQH	CD180	646	Q99467
RVSAKEKYYVWLQHT	CFLAR	456	O15519
LKNYYKILSLSAFWI	FAM200A	486	Q8TCP9
TAIEDRQYKDYKIHW	PRMT1	201	Q99873
YAKSVYWENTLHTLK	NUP107	291	P57740
KYFIHYSGWNKKSAV	MORF4L1	41	Q9UBU8
YTYDAKVKNFIQWIR	RADX	476	Q6NSI4
YKHNIYYWHVIAAKL	ANO6	821	Q4KMQ2
HNLKTKKIYFYWICR	NOX1	426	Q9Y5S8
KNWRHVYKSLTLMDY	ENTHD1	66	Q8IYW4
SYWKEVLLRYLHNFQ	KAT7	521	O95251
AVYTKVVHYRKWIKD	KLK2	241	P20151
YRSFYHKLKSKLNYW	MICAL3	46	Q7RTP6
YDHVFWYQKRLSTTS	IGLV2-33	51	A0A075B6J2
YRSIIKDYFHRGAKW	GATM	196	P50440
WLYHYRKTAKAKEEN	DYDC2	36	Q96IM9
KEHWYQKAILSKFLY	EDRF1	196	Q3B7T1
LKAAYNAYKAWLRKH	ECE2	716	P0DPD6
SLLGHYKWEKFVYLY	GRIA3	151	P42263
TSIYTKHLERWLKYF	HS3ST5	231	Q8IZT8
VYFYTFNSLKALWVK	SLC25A17	81	O43808
KRWFVLTHNSLDYYK	MYO10	1416	Q9HD67
TENWTKKKYHSYLER	MYCLP1	271	P12525
AIYDIVHRNKYKDWI	DSE	426	Q9UL01
FYREKWIYVHKESTK	FBXO25	81	Q8TCJ0
VIWRYFHDTLLRKYA	ENPP1	771	P22413
RHLFFANIDWDKLYK	RPS6KA6	326	Q9UK32
KNLYWTDSHYKSISV	LRP2	796	P98164
LNYSDHDVIKWVRYI	AP2M1	411	Q96CW1
ISAHRKLISSDYYIW	AP5M1	461	Q9H0R1
FVRVAYYAKWIHKII	HGF	706	P14210
YYAKWIHKIILTYKV	HGF	711	P14210
KEYKTDSFWRHTGYV	PLBD1	151	Q6P4A8
EYHKWRTYFKKRLQQ	MLXIP	221	Q9HAP2
TFKDYSVTLHWYKIL	KLRF1	26	Q9NZS2
SFYKVNHIWKFRYDR	DOCK4	1406	Q8N1I0
LWGAHYYRTQKLLSK	EGF	1051	P01133
WLKFHIGINRYELYS	FAM20C	226	Q8IXL6
KVSYLQLSFWKTYAQ	CALHM5	206	Q8N5C1
KSEFYHDEFKRWIYL	GAN	491	Q9H2C0
TFETVWQVKFYNYHK	CNRIP1	116	Q96F85
FYVERYSWSQLKKLL	DPP8	51	Q6V1X1
VKNKEQVRHFYYRTW	CRAMP1	206	Q96RY5
QVRHFYYRTWHKITK	CRAMP1	211	Q96RY5
YYRTWHKITKYIDFD	CRAMP1	216	Q96RY5
LRYDEHAYKWLSTLK	BBOX1	131	O75936
LFTFTKLYARHYAWT	ADCY9	161	O60503
GLKYDSKIYWTVHRN	C3orf33	186	Q6P1S2
QKEVAAWTYHYSTKA	SELP	36	P16109
LKKIYFYWLCRDTHA	CYBB	436	P04839
DQLYWKTIKAFQYVH	C1GALT1	141	Q9NS00
QSWKRSHKKATYVYE	FAM186A	456	A6NE01
HALRWYNHIKSYEKE	EEF1B2	51	P24534
KHFWEREIGKQTYYR	FAM240A	26	A0A1B0GVK7
SKTKTQYFHQEKWIY	FBXO32	71	Q969P5
VTKKTYEIWHRRHDY	CHD4	1721	Q14839
RVLRKWDFSKYYVSN	RUBCN	761	Q92622
YYVSNFSKDLLIKIW	RUBCN	771	Q92622
KAKIFYATQWLLYAQ	RXYLT1	171	Q9Y2B1
YASLFGWKFHLEYRK	DYSF	1071	O75923
LDYIWYSKHALNVRS	NOCT	376	Q9UK39
AVYHKGRFFKLWLYE	CPT1B	336	Q92523
LRELHLYSTWKKYQE	FAM153B	96	P0C7A2
GSLEWYYEHVKARFK	MLPH	116	Q9BV36
WDKLDHYYRIVKSTL	PHKB	46	Q93100
QEYHLYREKKTALWI	LILRA3	56	Q8N6C8
WDLYYHVFRRISKQL	MTOR	2101	P42345
HLYFWGYSEAAKKRI	MGST2	91	Q99735
SKQLYFLFSPKHYWR	PNPLA8	26	Q9NP80
VFVLAVKLKWFYYST	RNF139	191	Q8WU17
KRYLLSSAYVDSHKW	MRPS27	26	Q92552
KYRLTFYGNWSEKTH	SPON1	206	Q9HCB6
SAWYHVLKGEKTFYL	PHF2	256	O75151
HNFWKRYLQKSKQAY	TAF1B	106	Q53T94
KWSYSFIKKHRRRYS	NPY5R	276	Q15761
VWKFRYYLTNQEKAL	PIK3C3	316	Q8NEB9
KRYRYVYHSSKWMVA	TBX15	171	Q96SF7
KHQKITDSRYYTVRW	NEO1	881	Q92859
AYTTEHWLVRIYKVK	STT3A	681	P46977
TSWKRLIFYINHDFK	ST6GALNAC1	556	Q9NSC7
LQKFWQHRIKDYHSY	SUPT7L	231	O94864
EKFSKAIYKYVNHWR	MROH2B	156	Q7Z745
KWNYIYDKLSVHVTA	SIGLEC12	256	Q96PQ1
KLISLRHYYFTIGWN	SCN1A	1591	P35498
MKYIHYKLSQRGYEW	BCL2	16	P10415
LVWKFTYAHKYLLAD	ALG10	336	Q5BKT4
AVYSLLNIKYKSWYS	CLPTM1L	416	Q96KA5
GKAFTWFSYLIQHKR	ZNF695	386	Q8IW36
HFKVKWFYNEYVREL	UNC13C	1661	Q8NB66
TKYNNFDVYIKTRWL	TMEM250	36	H0YL14
NKRYRYVYHSSKWMV	TBX18	196	O95935
TSESYKNNKAKLYWH	SUN3	201	Q8TAQ9
KHFWFVIKNKVLYTY	FGD6	1351	Q6ZV73
IYYINHKNKTTSWLD	YAP1	246	P46937
LQKWKYNEFYHVKTS	ROS1	1691	P08922
HWVVFKETTLSYYKS	FERMT3	376	Q86UX7
IFTRLWIYSHHIYNK	RWDD2B	186	P57060
WSSRLTTHKKNYTRY	ZNF43	241	P17038
LQHLQIFTYERKWYS	ZNF598	151	Q86UK7
LVILIFYKWTAYDAH	ATP6V0A1	586	Q93050
HYISDVYDIKKQAWF	USP37	906	Q86T82
KEEYRIHITGKWFNY	TMEM117	291	Q9H0C3
YYQEKKHLEVARTWH	TTC37	126	Q6PGP7
SKFLKLNSHIWEYTY	UGGT2	421	Q9NYU1
AFKWSSYLNQHNKIY	ZNF732	566	B4DXR9
KLYYDKRWYHKSQAI	SUDS3	261	Q9H7L9
KRWYHKSQAIYLESK	SUDS3	266	Q9H7L9
LYQKLITSAHWKVYL	UBR4	4186	Q5T4S7
LQFSCYSSLKHLYKW	SLC25A19	191	Q9HC21
HVAYVFQALIYWIKA	UBR5	1946	O95071
KYNKIRLKETHEYWF	ZNF804A	576	Q7Z570
KRHVFYSTIDWNKLY	RPS6KA1	316	Q15418
WALGKTKVFLKYYHV	MYO3A	1031	Q8NEV4
HLRKLWSNYLYTDKA	NEB	5116	P20929